Michelle E Lewallen
Overview
Explore the profile of Michelle E Lewallen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
213
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caffrey T, Sagar S, Thomas D, Lewallen M, Hollingsworth M, Radhakrishnan P
FEBS Lett
. 2019 Jul;
593(19):2751-2761.
PMID: 31283009
Aberrant expression of the glycoprotein mucin-1 (MUC1) has been associated with pancreatic cancer progression and metastasis as a result of mediating the oncogenic transcriptional regulation of target genes. In the...
2.
Mohr A, Bailey J, Lewallen M, Liu X, Radhakrishnan P, Yu F, et al.
PLoS One
. 2013 Oct;
8(10):e73306.
PMID: 24143167
MUC1 is a transmembrane glycoprotein that modulates transcription via its cytoplasmic domain. We evaluated the capacity of MUC1 to regulate the global transcription of microRNAs in pancreatic cancer cells expressing...
3.
Chaika N, Gebregiworgis T, Lewallen M, Purohit V, Radhakrishnan P, Liu X, et al.
Proc Natl Acad Sci U S A
. 2012 Aug;
109(34):13787-92.
PMID: 22869720
Aberrant glucose metabolism is one of the hallmarks of cancer that facilitates cancer cell survival and proliferation. Here, we demonstrate that MUC1, a large, type I transmembrane protein that is...
4.
Eggers J, Grandgenett P, Collisson E, Lewallen M, Tremayne J, Singh P, et al.
Clin Cancer Res
. 2011 Aug;
17(19):6140-50.
PMID: 21825040
Purpose: To evaluate the nature of cyclin-dependent kinase 5 (CDK5) hyperactivity in pancreatic cancer progression. Experimental Design: We used genetic, biochemical, and molecular biology methods to investigate the nature and...